규제 업데이트

Ahead of a national audit, the Seoul City Pharmacists Association urged the National Assembly to prioritize patient safety and strengthen oversight before expanding telemedicine drug delivery and safety‑standby medicines.

The Korean Pharmaceutical Association will host a large rally on June 20 in Gwanghwamun, uniting pharmacists and pharmacy students to oppose the government's telemedicine and prescription‑delivery expansion, while also raising concerns about platform‑driven medical commercialization and health‑insurance financing.

The Ministry of Health and Welfare announced plans to create a dedicated permanent organization to tackle abnormal fake medical treatments, including fee paybacks and advance high‑cost payments.

Policy director Jeon Jin‑han cautions that the government's plan to broaden medication delivery for telemedicine patients could increase private platform control and push medical privatization.

Over three decades, the KPA has formed emergency committees for major policy issues, noting varied outcomes influenced by political, social and public factors.

Pharmacists and civil groups in South Korea are staging protests and a nationwide rally after a petition against remote prescription drug delivery gathered 50,000 signatures.

On June 13, pharmacists and allied health groups gathered in front of Seoul’s Blue House to protest the government's plan to broaden telemedicine‑based prescription drug delivery, urging a policy review.

The Korean Pharmacists Association held its first strategy meeting to plan a September 20 nationwide rally, focusing on protecting public health rights and opposing the expansion of telemedicine and drug delivery services.

The Korean pharmacist community is launching a full‑scale campaign against the government's plan to broaden delivery of prescription drugs for telemedicine, with the Korean Pharmaceutical Association forming an emergency task force.

The National Assembly’s Health and Welfare Committee presented 376 items—371 bills and 5 petitions—covering health, food‑medicine, and disease control, with a key Pharmacy Act amendment addressing warehouse‑type pharmacies.

The first regular Health and Welfare Committee meeting showed sharp partisan clashes, focusing on the MFDS’s responsibility linked to the Justice Minister nominee.

Following earlier network‑pharmacy and name‑restriction laws, a new bill targeting external capital in pharmacies entered discussion, aiming to limit operators to one outlet and ban terms like “warehouse.”